We use cookies to improve the performance of this website and to provide a better user experience. If you continue to use this site we'll assume you are happy to accept these cookies. If you want more information about our use of cookies please read our Terms of Use

Continue

The Servier Research Group announces the death of President-Founder Dr. Jacques Servier

Wexham, UK 17th April 2014
It is with great sadness that The Servier Research Group announces the death of President-Founder Dr. Jacques Servier read more ...


Life through Discovery

Servier has a unique cultural heritage as an independent French research based Foundation. We invest only in therapeutic areas where there is a real unmet medical need and develop truly innovative drugs to improve the quality of people’s lives.

Servier focuses its research in specific areas including:

  • Cardiovascular disease (angina, blood pressure, heart disease)
  • Metabolic disease (diabetes)
  • Rheumatology (osteoporosis)
  • Mental Health (depression)
  • Oncology (cancer)

Our current portfolio of medicinal products available in the UK is:

  • Coversyl Arginine (perindopril)
  • Coversyl Arginine Plus (perindopril and indapamide)
  • Diamicron MR (gliclazide)
  • Natrilix SR (indapamide)
  • Procoralan (ivabradine hydrochloride)
  • ▼ Protelos (strontium ranelate)
  • Valdoxan (agomelatine)

© 2013 LES LABORATOIRES SERVIER, an incorporated company of SERVIER. All Rights Reserved - Terms of Use
SERVIER does not sell its products over the Internet - More information
Last Updated 17/04/2014 15:28:24